Representatives from Taylor Farms, one of the largest produce suppliers in the United States, reportedly reached out to the White House seeking to delay the public announcement of a recall linked to a widespread cyclospora outbreak. The company requested additional evidence and more time to address its potential role in the outbreak, which has affected thousands of people across multiple states.
The outbreak, which causes severe gastrointestinal illness, has prompted significant concern among federal health officials. Earlier in July, the Food and Drug Administration (FDA) was preparing to publicly associate Taylor Farms with the multistate parasitic infection traced to shredded iceberg lettuce served by Taco Bell. However, Taylor Farms expressed doubts about the evidence connecting its products to the outbreak and requested greater clarity on the investigation and scope of the recall.
During a conference call arranged by the White House, Taylor Farms raised concerns that the government possessed no positive laboratory confirmation tying its lettuce to the pathogen and warned that the company’s responsibility was being overstated. The White House involved FDA officials in the discussion to ensure the agency’s findings were clearly communicated and to prepare for potential public scrutiny. Ultimately, the White House accepted the FDA’s conclusion and authorized the agency to disclose its findings.
On July 16, the FDA announced it was investigating illnesses in five states linked to a single supplier in Mexico, without naming Taylor Farms due to trade secret protections. The following day, Taylor Farms voluntarily recalled all iceberg lettuce sourced from central Mexico, stating it had promptly removed all potentially affected products as a precaution.
A week later, the FDA reported a positive cyclospora test on a sample of Taylor Farms lettuce not included in the company’s recall, suggesting the contamination could be more extensive. However, the agency retracted the positive result days later, citing a false positive. This reversal created confusion and led Taylor Farms to highlight an FDA apology in its public response. The FDA denied issuing an official apology, and the company later removed social media posts referencing it, although its original statement remained on its website.
Despite the laboratory test reversal, health officials emphasized that strong epidemiological data continued to link Taylor Farms to the outbreak, and the recall remained in effect. Some former government officials have criticized the FDA’s handling of the situation. Frank Yiannas, a former FDA deputy commissioner, described the agency’s response as slow, noting that illnesses linked to cyclospora began in mid-May, but the first federal advisory was not issued until two months later. Yiannas also contended that the FDA should have disclosed the implicated supplier sooner and verified laboratory results before public announcements.
The investigation into the source of the outbreak and the scope of the contaminated products remains ongoing as public health authorities work to prevent further illnesses.
